Search
Tandem Diabetes Care Inc
TNDMAdd to Watchlist
16.910USD
-1.080-6.00%
Close 11-06 16:00（ET）
1.18BMarket Cap
LossP/E TTM
Pre-market 07:09 (ET)16.900USD-0.010-0.06%
Pre-market 07:09 (ET)Tandem Diabetes Care Inc (TNDM) Stock Price Target & Forecast
Analyst Rating
Based on 23 analysts giving stock ratings to Tandem Diabetes Care Inc in the past month.
Buy
5 Strong Buy
8 Buy
10 Hold
0 Sell
0 Strong Sell
Target Price
28.150USD+47.31%
TNDM Analyst Recommendation Trends
In the current month, TNDM has received 8 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. TNDM average Analyst price target in the last month is 28.150.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
5
5
4
4
4
4
4
4
8
8
8
8
8
8
8
6
10
10
10
11
11
11
11
14
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23
23
22
23
23
23
23
24
TNDM Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
10
14
6
0
0
30
Dexcom Inc
DXCM
13
12
4
0
0
29
Medtronic PLC
MDT
8
11
10
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Abbott Laboratories
ABT
11
13
4
0
0
28
Guardant Health Inc
GH
12
14
2
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
5
20
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Repligen Corp
RGEN
5
12
4
0
0
21
Alcon AG
ALC
6
9
3
1
0
19
Financial Forecasting
Based on analysts' estimates, TNDM EPS is projected to reach 0.169 in FY2026Q4, following reported EPS of -0.102 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.44
-0.32
-0.24
0.17
-0.11
Actual
-0.30
-0.31
-0.10
--
--
Surprise
+32.89%
+4.07%
+58.02%
--
--
FAQs
What is Tandem Diabetes Care Inc's expected revenue for the next quarter?
Tandem Diabetes Care Inc's expected revenue is 304.62M.
What is Tandem Diabetes Care Inc's price target?
Analysts forecast that Tandem Diabetes Care Inc's price target is USD 28.15, with the highest forecast at USD 50.00 and the lowest forecast at USD 18.00.
How have Tandem Diabetes Care IncTNDM's recent earnings per share performed?
The market expectation was USD -0.10, while Tandem Diabetes Care IncTNDM's earnings per share (EPS) for the previous quarter was USD -0.31. EPS for the next quarter is expected at USD 0.17.
What is the analyst rating for Tandem Diabetes Care Inc?
Based on the ratings of Tandem Diabetes Care Inc's stock from 23 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.